Galena Biopharma Inc (NASDAQ:GALE) has announced it will have two post presentations at next week’s San Antonio Breast Cancer Symposium: “VADIS Trial: Phase …
In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …
Galena Biopharma Inc (NASDAQ:GALE) committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, today announced that …
Yesterday, Galena Biopharma Inc (NASDAQ:GALE) released third-quarter earnings and offered a clinical progress update on its pipeline. In reaction, Maxim analyst Jason McCarthy …
Galena Biopharma Inc (NASDAQ:GALE) reported its financial results and provided a corporate update for the quarter ended September 30, 2016. “Over the past …
Galena Biopharma Inc (NASDAQ:GALE) announced that Stephen F. Ghiglieri has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective immediately.
Galena Biopharma Inc (NASDAQ:GALE) announced that on October 26, 2016, the Board of Directors approved a reverse stock split of its shares of common …
Galena Biopharma Inc (NASDAQ:GALE) shares are climbing almost 12% today after the biotech firm presented data from its Phase 1b trial that evaluates patient’s …
Galena Biopharma, Inc. (NASDAQ:GALE) announced that Dr.
In a research report released yesterday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), with a price …